HCMT
AMRI

Highland Capital Management (Texas)’s Albany Molecular Research Inc AMRI Stock Holding History

Highland Capital Management (Texas)’s Portfolio AMRI Stock Details AMRI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-234,441
Closed -$3.82M – 274
2014
Q4 		$3.82M Buy
234,441
+53,396
+29% +$980K 0.13% 114
2014
Q3 		$4M Buy
181,045
+20,065
+12% +$411K 0.15% 124
2014
Q2 		$3.24M Buy
160,980
+2,439
+2% +$41.3K 0.12% 118
2014
Q1 		$2.95M Buy
+158,541
New +$2.18M 0.12% 116

Other funds holding AMRI

Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
PIP
Permian Investment Partners Dallas, Texas $905M AUM 13.43% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
VNIM
Vaughan Nelson Investment Management Houston, Texas $11.3B AUM 53% 1-Year Est. Return
OWP
Obermeyer Wealth Partners Aspen, Colorado $2.17B AUM 19.33% 1-Year Est. Return
VAM
Visium Asset Management New York $1.43B AUM 3.58% 1-Year Est. Return
EWM
Evercore Wealth Management New York $6.36B AUM 20.35% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

Highland Capital Management (Texas)'s AMRI Position: Q1 2015 in Review

Highland Capital Management (Texas) sold out of Albany Molecular Research Inc (AMRI) in Q1 2015, closing a stake of 234,441 shares — an estimated $3.82M sold.

Highland Capital Management (Texas) first reported a position in AMRI in Q1 2014 and held it in 4 quarters. The position peaked at $4M in Q3 2014. 131 funds tracked by Wall St. Rank hold AMRI as of Q1 2015.

  • Highland Capital Management (Texas) reported no remaining Albany Molecular Research Inc position as of Q1 2015 after selling out during the quarter.
  • Highland Capital Management (Texas) sold 234,441 Albany Molecular Research Inc shares in Q1 2015, an estimated $3.82M.
  • Highland Capital Management (Texas) first reported a position in Albany Molecular Research Inc in Q1 2014 and held it in 4 quarters.
  • Highland Capital Management (Texas)'s Albany Molecular Research Inc position peaked at $4M in Q3 2014.
  • 131 funds tracked by Wall St. Rank held Albany Molecular Research Inc as of Q1 2015.

Based on Highland Capital Management (Texas)'s 13F filing for Q1 2015, filed 15 May 2015.